1 – 5 of 19
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator
(
- Contribution to journal › Article
- 2021
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2019
-
Mark
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE) : a cost minimisation analysis
(
- Contribution to journal › Article
-
Mark
Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms
(
- Contribution to journal › Scientific review
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article